JFrog Ltd. Ordinary Shares vs Roivant Sciences Ltd. Common Shares — how do they compare? JFrog Ltd. Ordinary Shares trades at $97.61 (market cap $12.10B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.1× JFrog Ltd. Ordinary Shares's market cap, and JFrog Ltd. Ordinary Shares is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| FROG | ROIV | |
|---|---|---|
Market Cap | $12.10B | $25.09B |
Volume | 773,694 | 5,738,571 |
Sector | Technology | Health |
52-Week High | $104.03 | $41.81 |
52-Week Low | $34.75 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.29B | $21.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →